Clinical Trial Update: A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial ROSETTA is evaluating the efficacy and safety of Rosnilimab in moderate to severe ulcerative colitis and is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Rosnilimab (Rosnilimab)

Snippet

Sponsor: AnaptysBio, Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING